These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 16554841)

  • 1. Topical antiviral siRNA: a practical siRNA microbicide?
    Rossi JJ
    Gene Ther; 2006 Nov; 13(21):1493-4. PubMed ID: 16554841
    [No Abstract]   [Full Text] [Related]  

  • 2. Silencing herpes simplex virus with a vaginal microbicide.
    Johnson DC
    N Engl J Med; 2006 Mar; 354(9):970-1. PubMed ID: 16510753
    [No Abstract]   [Full Text] [Related]  

  • 3. An siRNA-based microbicide protects mice from lethal herpes simplex virus 2 infection.
    Palliser D; Chowdhury D; Wang QY; Lee SJ; Bronson RT; Knipe DM; Lieberman J
    Nature; 2006 Jan; 439(7072):89-94. PubMed ID: 16306938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of bovine viral diarrhea virus replication by small interfering RNA and short hairpin RNA-mediated RNA interference.
    Lambeth LS; Moore RJ; Muralitharan MS; Doran TJ
    Vet Microbiol; 2007 Jan; 119(2-4):132-43. PubMed ID: 17052865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Study on the inhibition effect of siRNA on herpes simplex virus type 2 ICP4 gene].
    Liu JF; Guan CP; Tang X; Xu AE
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2010 Jun; 24(3):199-201. PubMed ID: 21186526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of herpes simplex virus type 1-based amplicon vector for delivery of small interfering RNA.
    Sabbioni S; Callegari E; Manservigi M; Argnani R; Corallini A; Negrini M; Manservigi R
    Gene Ther; 2007 Mar; 14(5):459-64. PubMed ID: 17051250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of chronic hepatitis B virus infection: a promising approach using small interfering RNA (siRNA).
    Dwivedi M; Misra SP; Misra V; Waikhom RK; Bhatnagar M
    Natl Med J India; 2008; 21(3):123-7. PubMed ID: 19004143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effective inhibition of hepatitis B virus replication by small interfering RNAs expressed from human foamy virus vectors.
    Sun Y; Li Z; Li L; Li J; Liu X; Li W
    Int J Mol Med; 2007 Apr; 19(4):705-11. PubMed ID: 17334648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Progression of RNA interference technology and its application in the research of gene function and gene therapy].
    Lü H; He ZM
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2005 Feb; 30(1):102-5. PubMed ID: 15871202
    [No Abstract]   [Full Text] [Related]  

  • 10. [Effect of L-lysine-A-oxidase on development of herpetic genital infection in guinea pigs].
    Smirnova IP; Alekseev SB; Diorditsa SV; Vesa VS; Zaĭtseva IZ
    Biull Eksp Biol Med; 1999 Dec; 128(12):654-6. PubMed ID: 10650465
    [No Abstract]   [Full Text] [Related]  

  • 11. RNA interference strategies as therapy for respiratory viral infections.
    DeVincenzo JP
    Pediatr Infect Dis J; 2008 Oct; 27(10 Suppl):S118-22. PubMed ID: 18820571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effective small interfering RNAs targeting matrix and nucleocapsid protein gene inhibit influenza A virus replication in cells and mice.
    Zhou H; Jin M; Yu Z; Xu X; Peng Y; Wu H; Liu J; Liu H; Cao S; Chen H
    Antiviral Res; 2007 Nov; 76(2):186-93. PubMed ID: 17719657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interference RNA technology in the treatment of CNV.
    Tolentino M
    Ophthalmol Clin North Am; 2006 Sep; 19(3):393-9, vi-vii. PubMed ID: 16935214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RNA interference in the mouse vascular endothelium by systemic administration of siRNA-lipoplexes for cancer therapy.
    Santel A; Aleku M; Keil O; Endruschat J; Esche V; Durieux B; Löffler K; Fechtner M; Röhl T; Fisch G; Dames S; Arnold W; Giese K; Klippel A; Kaufmann J
    Gene Ther; 2006 Sep; 13(18):1360-70. PubMed ID: 16625242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effective inhibition of infectious bursal disease virus replication in vitro by DNA vector-based RNA interference.
    Gao Y; Liu W; Gao H; Qi X; Lin H; Wang X; Shen R
    Antiviral Res; 2008 Aug; 79(2):87-94. PubMed ID: 18378010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nonviral in vivo delivery of therapeutic small interfering RNAs.
    Aigner A
    Curr Opin Mol Ther; 2007 Aug; 9(4):345-52. PubMed ID: 17694447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specific inhibition of orthopoxvirus replication by a small interfering RNA targeting the D5R gene.
    Vigne S; Germi R; Duraffour S; Larrat S; Andrei G; Snoeck R; Garin D; Crance JM
    Antivir Ther; 2008; 13(3):357-68. PubMed ID: 18572748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo gene silencing in solid tumors by targeted electrically mediated siRNA delivery.
    Golzio M; Mazzolini L; Ledoux A; Paganin A; Izard M; Hellaudais L; Bieth A; Pillaire MJ; Cazaux C; Hoffmann JS; Couderc B; Teissié J
    Gene Ther; 2007 May; 14(9):752-9. PubMed ID: 17344906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RNAi tackles a sexually transmitted disease.
    Cristofaro P; Ramratnam B
    Nat Biotechnol; 2006 Jan; 24(1):48-9. PubMed ID: 16404395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of scratching behavior by silencing an endogenous cyclooxygenase-1 gene in the skin through the administration of siRNA.
    Inoue T; Sugimoto M; Sakurai T; Saito R; Futaki N; Hashimoto Y; Honma Y; Arai I; Nakaike S
    J Gene Med; 2007 Nov; 9(11):994-1001. PubMed ID: 17703497
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.